期刊文献+

一氧化氮在慢性阻塞性肺疾病中的作用机制及应用价值 被引量:5

The Mechanism of Action and Applied Value of Nitric Oxide in Chronic Obstructive Pulmonary Disease
原文传递
导出
摘要 慢性阻塞性肺疾病(COPD)是一种以不完全可逆性气流受限及气道持续性炎症为特征的疾病,呈进行性发展,临床上以进行性呼出气流减少、呼气末容量增大、低氧血症、高碳酸血症和进行性肺动脉高压为特征。在COPD的病理生理过程中,由于炎性因子或介质、血管内皮、血小板、黏附因子的作用,逐渐产生血栓前状态,导致COPD患者肺部微小动脉血栓形成,肺血管重构,导致肺动脉高压,最终引起右心衰竭。因此,肺动脉高压是COPD发展至肺心病的关键环节,阐明肺动脉高压的形成机制,并寻求理想的降低肺动脉高压的方法,一直是防治COPD、肺心病的重要研究课题。一氧化氮(NO)是近年来发现的生物活性物质之一,其可作为神经递质、信使及调节因子等参与机体许多生理、病理过程。NO具有广泛的功能,如血管调节、神经传导、宿主防御及细胞毒性作用。越来越多的研究表明NO参与肺血管张力调节及肺血管结构重建,在由COPD向肺心病的发展过程中以及在调节肺功能和肺疾病中起着重要作用。因此,本文就一氧化氮在慢性阻塞性肺疾病发展过程中的作用机制及其应用价值进行综述,以期为COPD更好的治疗提供依据。 Chronic obstructive pulmonary disease(COPD) is a progressive disease characterized by irreversible airway obstruction and persistent airway inflammation and which is clinically characterized by progressive expired gas reduction,end-expiratory volume increase,hyoxemia,hypercapnia and progressive pulmonary hypertension.In the COPD pathophysiological events,due to the role of inflammatory factor or medium,vascular endothelium,platelet and adhesion factor,the body gradually produces former thrombosis state,resulting in patients with COPD lung tiny arterial thrombosis,pulmonary vascular remodeling,causing pulmonary arterial hypertension,and resulting in right heart failure at last.Therefore,pulmonary hypertension is the key link to the development of COPD to cor pulmonale.Clarifying the formation mechanism of pulmonary hypertension and seeking the ideal method for reducing pulmonary arterial hypertension are important research subjects for COPD or cor pulmonale prevention.Nitric oxide(NO) is one of biological activity materials,which is found in recent years.It can be used as neurotransmitter,messenger and regulatory factor to participate in many physiological and pathological processes of the body.NO has extensive functions,such as vascular adjustment,nerve conduction,host defense and cytotoxic effect.More and more studies show NO participating in pulmonary vascular tension adjustment and pulmonary vascular structures reconstruction.It plays an important role in the development process of COPD to cor pulmonale and in regulation of lung function and pulmonary diseases.Therefore,mechanism of action and application value of nitric oxide in the development process of chronic obstructive pulmonary disease are reviewed in this article so as to provide a basis for better treatment of COPD.
作者 刘波 霍建民
出处 《实用预防医学》 CAS 2011年第7期1385-1386,F0003,1329,共4页 Practical Preventive Medicine
关键词 一氧化氮 慢性阻塞性肺疾病 一氧化氮合酶 血管重建 Nitric oxide COPD Nitric oxide synthase Vascular remodeling
  • 相关文献

参考文献26

  • 1Santos S, Peinado VI, Ramiez J, et al. Characterization of pulmonary vascular remodeling in smokers and patients with mild COPD[J ]. Eur Respir J ,2002,19:632 - 638.
  • 2Volke NF, Cool CD. Pulmonary vascular involvement in chronic obstructive pulmonary disease [ J ]. Eur Respir J, 2003,46 (Suppl) : 28s - 32s.
  • 3Barbera JA,Peinado V1, Santos S. Pulmonary hypertension in COPD: old and new concepts[J ]. Monaldi Arch Chest Dis, 2000, 55:445 449.
  • 4Marsden PA, Heng HH, Scherer SW, et al. Struture and chromosomal localization of the human constitutive endothelial nitric oxide synthase [J]. L Biol Chem, 1993,268(33) : 17478 - 17488.
  • 5Gelle DA, Lowenstein CJ ,Shapiro RA, et al. Molecular cloning and expression of indacible nitric oxide synthase frome human hepatocytes [J~, Proc Natl Acad Sci USA, 1993,90(8) :3491 - 3495,.
  • 6Barnes PJ, Belvisi MG. Nitric oxide and lung disease[J ]. Thorat, 1993, 48:1034-1043.
  • 7Gaston B,Drazen JM, Loscalzo J, et al. The biology of nitrogen oxide in the airway[ J ]. Am J Respir Crit Care Med, 1994,149 : 538 - 551.
  • 8Ricciardolo FL. Multiple roles of nitric oxide in the airways[ J ]. Thorax, 2003,58:175 182.
  • 9Migneauh A, Sauvageau S. Chronically elevated endothelin levels reduce pulmonary vascular reactivity to nitric oxide[J]. Am J Respir Crit Care Med,2005,171(5):506 513.
  • 10颜浩,周黎强,黎怀碧,张蕾.肺心病患者急性加重期血清一氧化氮、内皮素及心钠素含量变化的意义[J].四川医学,2000,21(6):477-478. 被引量:10

二级参考文献17

  • 1李靖,郑劲平,袁锦屏,杨灵,罗锭芬,安嘉颍,肖正伦,钟南山,钟维农,何为国,赵子文,曾军,林材元.口服八种细菌提取物对慢性支气管炎合并慢性阻塞性肺疾病急性加重的预防作用[J].中华结核和呼吸杂志,2004,27(9):631-633. 被引量:29
  • 2Cooper CJ, Landzberg MJ, Anderson TJ, et al. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans.Circulation, 1996,93:266-270.
  • 3Ruschitzka F, Shaw S, Gygi D, et al.Endothelial dysfunction in acute renal failure:role of circulating and tissue endothelin-1. J Am Soc Nephrol,1999,10(5):953-962.
  • 4Wang HR, Carcillo JA, Burckart G, et al. Increased serum nitrite and nitrate concentrations in children with sepsis syndrome. Crit Care Med, 1995,23:835-842.
  • 5Fineman JR, Wong J, Morin FC, et al. Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. J Clin Invest, 1994,93:2 675-2 683.
  • 6Williamson DJ, Hayward C, Rosers P, et al. Acute bemocynamic responses to inhale nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension. Circulation,1996,94:477-482.
  • 7Clini E,Cremona G,Campana M,et al. Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale:correlates with echo-Doppler assessment. Am J Respir Crit Care Med,2000,162:446-450.
  • 8Corradi M, Pesci A, Casana R, et al. Nitrate in exhaled breath condensate of patients with different airway diseases. Nitric Oxide,2003,8:26-30.
  • 9Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax, 2003,58 :294-298.
  • 10Carpagnano GE, Resta O, Foschino-Barbaro MP, et al. Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease:effect of carbocysteine lysine salt monohydrate (SCMCLys). Eur J Pharmacol,2004,505 : 169-175.

共引文献38

同被引文献77

引证文献5

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部